Cargando…

What is synergy? The Saariselkä agreement revisited

Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jing, Wennerberg, Krister, Aittokallio, Tero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555011/
https://www.ncbi.nlm.nih.gov/pubmed/26388771
http://dx.doi.org/10.3389/fphar.2015.00181
_version_ 1782388114090622976
author Tang, Jing
Wennerberg, Krister
Aittokallio, Tero
author_facet Tang, Jing
Wennerberg, Krister
Aittokallio, Tero
author_sort Tang, Jing
collection PubMed
description Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of synergy. Two popular reference models for null hypothesis include the Bliss independence model and the Loewe additivity model, each of which is formulated from different perspectives. During the last century, there has been an intensive debate on the suitability of these synergy models, both of which are theoretically justified and also in practice supported by different schools of scientists. More than 20 years ago, there was a community effort to make a consensus on the terminology one should use when claiming synergy. The agreement was formulated at a conference held in Saariselkä, Finland in 1992, stating that one should use the terms Bliss synergy or Loewe synergy to avoid ambiguity in the underlying models. We review the theoretical relationships between these models and argue that one should combine the advantages of both models to provide a more consistent definition of synergy and antagonism.
format Online
Article
Text
id pubmed-4555011
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-45550112015-09-18 What is synergy? The Saariselkä agreement revisited Tang, Jing Wennerberg, Krister Aittokallio, Tero Front Pharmacol Pharmacology Many biological or chemical agents when combined interact with each other and produce a synergistic response that cannot be predicted based on the single agent responses alone. However, depending on the postulated null hypothesis of non-interaction, one may end up in different interpretations of synergy. Two popular reference models for null hypothesis include the Bliss independence model and the Loewe additivity model, each of which is formulated from different perspectives. During the last century, there has been an intensive debate on the suitability of these synergy models, both of which are theoretically justified and also in practice supported by different schools of scientists. More than 20 years ago, there was a community effort to make a consensus on the terminology one should use when claiming synergy. The agreement was formulated at a conference held in Saariselkä, Finland in 1992, stating that one should use the terms Bliss synergy or Loewe synergy to avoid ambiguity in the underlying models. We review the theoretical relationships between these models and argue that one should combine the advantages of both models to provide a more consistent definition of synergy and antagonism. Frontiers Media S.A. 2015-09-01 /pmc/articles/PMC4555011/ /pubmed/26388771 http://dx.doi.org/10.3389/fphar.2015.00181 Text en Copyright © 2015 Tang, Wennerberg and Aittokallio. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tang, Jing
Wennerberg, Krister
Aittokallio, Tero
What is synergy? The Saariselkä agreement revisited
title What is synergy? The Saariselkä agreement revisited
title_full What is synergy? The Saariselkä agreement revisited
title_fullStr What is synergy? The Saariselkä agreement revisited
title_full_unstemmed What is synergy? The Saariselkä agreement revisited
title_short What is synergy? The Saariselkä agreement revisited
title_sort what is synergy? the saariselkä agreement revisited
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555011/
https://www.ncbi.nlm.nih.gov/pubmed/26388771
http://dx.doi.org/10.3389/fphar.2015.00181
work_keys_str_mv AT tangjing whatissynergythesaariselkaagreementrevisited
AT wennerbergkrister whatissynergythesaariselkaagreementrevisited
AT aittokalliotero whatissynergythesaariselkaagreementrevisited